Scenarios | ALE (years) | Gain in ALE relative to Base scenario (years) | ||
---|---|---|---|---|
Men | 95 % CI | Men | 95 % CI | |
Base scenario | 29.08 | 28.77,29.39 | - | - |
0 % prevalence <30 years | 29.23 | 28.86, 29.53 | 0.16 | -.17,.44 |
10 % prevalence <30 years* | 29.19 | 28.89, 29.50 | 0.11 | 0.10,0.12 |
0 % prevalence <40 years | 29.48 | 29.15,29.79 | 0.40 | 0.36,0.43 |
10 % prevalence <40 years | 29.34 | 29.02, 29.65 | 0.26 | 0.25,0.27 |
0 % prevalence <50 years | 29.67 | 29.34,30.01 | 0.6 | 0.57,0.62 |
10 % prevalence <50 years | 29.43 | 29.10, 29.75 | 0.358 | 0.330.36 |
0 % prevalence <60 years | 29.82 | 29.18,30.46 | 0.74 | 0.62,0.82 |
10 % prevalence <60 years | 29.48 | 29.16, 29.81 | 0.4 | 0.39,0.42 |
0 % prevalence <70 years | 29.90 | 29.55,30.25 | 0.82 | 0.78,0.86 |
10 % prevalence <70 years | 29.49 | 29.11, 29.87 | 0.41 | 0.1,0.82 |
0 % prevalence <80 years | 29.92 | 29.47,30.18 | 0.85 | 0.8 ,0.89 |
10 % prevalence <80 years | 29.47 | 29.09, 29.85 | 0.39 | 0.12,0.66 |
10 % prevalence in entire population | 29.46 | 29.14, 29.81 | 0.39 | 0.36,0.43 |
0 % prevalence in entire population | 29.94 | 29.62,30.39 | 0.86 | 0.72,1.0 |